Ahmed Elsharkawy/LinkedIn
Sep 23, 2026, 00:02
Ahmed Elsharkawy: Drug-Drug and Drug-Diluent Incompatibilities in ICUs and Hematology Units
Ahmed Elsharkawy, ICU and Oncology Clinical Pharmacist at Children’s Cancer Hospital Foundation 57357, shared a post on LinkedIn:
“One of the major roles of Clinical pharmacist is to check Drug-Drug and Drug-Diluent incompatibilities especially for patients in ICUs and hematology units as they are considered a high-risk group for the occurrence of incompatibilities because they commonly require the use of multiple drugs, most of which are administered intravenously and by continuous infusion.
Potential complications of co-administration of incompatible drugs include:
- Precipitation
- Central venous catheter (CVC) occlusion or malfunction
- Reduced potency of medication
- Embolism and local or systemic inflammatory reactions.”
Stay updated with Hemostasis Today.
-
Sep 23, 2026, 00:08Janar Sathananthan: The Importance of Durable Drug Delivery in DCB Therapy
-
Sep 23, 2026, 00:07Arun V J: How Does a Good Conference Destroy My Ego?
-
Sep 23, 2026, 00:06Akshat Jain: Sickle Cell Disease Is Not One Size Fits All
-
Sep 23, 2026, 00:05Sherri Ozawa: Nicole De Vita’s Iron Deficiency Infographic Recognized at SABM
-
Sep 23, 2026, 00:04Zafar Ali: How Does Hemoglobin Know When to Hold Oxygen and When to Let It Go?
-
Sep 22, 2026, 23:58Nishant Rajendra Tiwari: Hereditary TTP With the Same ADAMTS13 Variants but Strikingly Different Disease Courses
-
Sep 22, 2026, 23:57Akhil Santhosh: Pacritinib Versus Ruxolitinib in Myelofibrosis With Thrombocytopenia
-
Sep 22, 2026, 23:56Nathan Punwani: EASIX and sC5b-9 Predict TMA After Allogeneic Stem Cell Transplantation
-
Sep 22, 2026, 19:02Blocking Histone-Induced Platelet-Erythrocyte Interactions With Polyanions – Platelets Journal